Other substances

Thymopentin

An immunostimulant.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Thymopentin on PubChem

 

Structure image - Thymopentin

CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N

Supporting references

Link Tested on Impact factor Notes Publication date
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Spike protein 3CLpro In silico 		in silico 4.07

Predicted to bind the SARS-CoV-2 spike protein.

 Sep/07/2020

AI-suggested references

Link Publication date
Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors.
Mar/23/2021
Export (.csv)